COVID-19 Testing in Patients With Vascular Disorders

计划入组 2,243 人 · 首次发布于 2021 年 4 月 8 日

Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders

计划入组 16 人 · 首次发布于 2003 年 10 月 16 日

VELOS for the Treatment of Vascular Lesions and Skin Rejuvenation

计划入组 60 人 · 首次发布于 2015 年 6 月 10 日

Nylidrin(Arlidin)

C₁₉H₂₅NO₂

vascular agents

Stromal Vascular Fraction

Institute For Neurodegenerative Disorders

United States

Lemaitre Vascular

United States

BASECAMP VASCULAR

France

Long Non-coding RNAs Emerge as Key Regulators of Vascular Endothelium and Angiogenesis

CHMP Recommends Aflibercept Biosimilar OPUVIZ for Retinal Disorders

Formycon's Aflibercept Biosimilar (FYB203) Gains EU Approval for Retinal Diseases